Published in Pharmacol Biochem Behav on February 01, 2010
Conditioned reinforcement and locomotor activating effects of caffeine and ethanol combinations in mice. Pharmacol Biochem Behav (2013) 0.88
Ethylphenidate as a selective dopaminergic agonist and methylphenidate-ethanol transesterification biomarker. J Pharm Sci (2014) 0.87
Interactive effects of methylphenidate and alcohol on discrimination, conditioned place preference and motor coordination in C57BL/6J mice. Psychopharmacology (Berl) (2012) 0.87
Transdermal and oral dl-methylphenidate-ethanol interactions in C57BL/6J mice: transesterification to ethylphenidate and elevation of d-methylphenidate concentrations. J Pharm Sci (2011) 0.84
Effects of vigabatrin, an irreversible GABA transaminase inhibitor, on ethanol reinforcement and ethanol discriminative stimuli in mice. Behav Pharmacol (2012) 0.84
Oral and transdermal DL-methylphenidate-ethanol interactions in C57BL/6J mice: potentiation of locomotor activity with oral delivery. Pharmacol Biochem Behav (2011) 0.82
Sensitization and Tolerance Following Repeated Exposure to Caffeine and Alcohol in Mice. Alcohol Clin Exp Res (2015) 0.81
Comparative Ethanol-Induced Potentiation of Stimulatory Responses to Dexmethylphenidate Versus Methylphenidate. J Clin Psychopharmacol (2015) 0.80
The discriminative stimulus properties of methylphenidate in C57BL/6J mice. Behav Pharmacol (2011) 0.79
Are there any potentially dangerous pharmacological effects of combining ADHD medication with alcohol and drugs of abuse? A systematic review of the literature. BMC Psychiatry (2015) 0.79
Chronic methylphenidate treatment during early life is associated with greater ethanol intake in socially isolated rats. Alcohol Clin Exp Res (2014) 0.78
Chronic methylphenidate exposure during adolescence reduces striatal synaptic responses to ethanol. Eur J Neurosci (2013) 0.78
Influence of sensitization on the discriminative stimulus effects of methylphenidate in mice. Behav Pharmacol (2014) 0.76
Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry (2007) 13.57
Attention-deficit hyperactivity disorder. Lancet (2005) 5.75
Development and validation of the Biphasic Alcohol Effects Scale. Alcohol Clin Exp Res (1993) 4.03
Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy (2006) 3.40
Voluntary consumption of ethanol in 15 inbred mouse strains. Psychopharmacology (Berl) (1993) 3.29
The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse? Neurosci Biobehav Rev (2005) 3.17
Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry (2006) 2.72
Neuropharmacology of alcohol addiction. Br J Pharmacol (2008) 2.65
Biphasic alcohol response differs in heavy versus light drinkers. Alcohol Clin Exp Res (2002) 2.39
Simultaneous and concurrent polydrug use of alcohol and prescription drugs: prevalence, correlates, and consequences. J Stud Alcohol (2006) 2.11
Prevalence and correlates of illicit methylphenidate use among 8th, 10th, and 12th grade students in the United States, 2001. J Adolesc Health (2004) 1.89
Repeated cycles of chronic intermittent ethanol exposure in mice increases voluntary ethanol drinking and ethanol concentrations in the nucleus accumbens. Psychopharmacology (Berl) (2008) 1.76
Why we like to drink: a functional magnetic resonance imaging study of the rewarding and anxiolytic effects of alcohol. J Neurosci (2008) 1.61
Intensity and duration of chronic ethanol exposure is critical for subsequent escalation of voluntary ethanol drinking in mice. Alcohol Clin Exp Res (2009) 1.59
Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther (2007) 1.56
Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis. Am J Hum Genet (2008) 1.50
Ethanol consumption by C57BL/6 mice: influence of gender and procedural variables. Alcohol (1999) 1.48
Neurochemical bases of locomotion and ethanol stimulant effects. Int Rev Neurobiol (1996) 1.43
Oral methylphenidate-alcohol co-abuse. J Clin Psychopharmacol (2002) 1.35
Slowing of growth in height and weight on stimulants: a characteristic pattern. J Paediatr Child Health (2003) 1.32
Sensitivity and tolerance to the hypnotic and ataxic effects of ethanol in adolescent and adult C57BL/6J and DBA/2J mice. Alcohol Clin Exp Res (2008) 1.27
A microdialysis profile of beta-endorphin and catecholamines in the rat nucleus accumbens following alcohol administration. Psychopharmacology (Berl) (2003) 1.23
Ethylphenidate formation in human subjects after the administration of a single dose of methylphenidate and ethanol. Drug Metab Dispos (2000) 1.23
Pharmacology of the enantiomers of threo-methylphenidate. J Pharmacol Exp Ther (1987) 1.19
Detection of the novel metabolite ethylphenidate after methylphenidate overdose with alcohol coingestion. J Clin Psychopharmacol (1999) 1.17
Ethanol-induced increases in dopamine extracellular concentration in rat nucleus accumbens are accounted for by increased release and not uptake inhibition. Alcohol (2000) 1.13
Stimulant actions in rodents: implications for attention-deficit/hyperactivity disorder treatment and potential substance abuse. Biol Psychiatry (2005) 1.11
Devaluation of ethanol reinforcement. Alcohol (2004) 1.06
ADHD in adults. N Engl J Med (2006) 1.01
Growth of hyperactive children on maintenance regimen of methylphenidate. Arch Gen Psychiatry (1983) 1.01
Naltrexone effects on ethanol consumption and response to ethanol conditioned cues in C57BL/6 mice. Psychopharmacology (Berl) (2000) 1.00
Methylphenidate in treatment of adults with Attention-Deficit/Hyperactivity Disorder. J Atten Disord (2002) 1.00
Following alcohol consumption, nontreatment-seeking alcoholics report greater stimulation but similar sedation compared with social drinkers. J Stud Alcohol (2004) 0.99
Voluntary ethanol drinking in mice and ethanol concentrations in the nucleus accumbens. Brain Res (2006) 0.98
Methylphenidate reduces energy intake and dietary fat intake in adults: a mechanism of reduced reinforcing value of food? Am J Clin Nutr (2007) 0.97
Safety of therapeutic methylphenidate in adults: a systematic review of the evidence. J Psychopharmacol (2008) 0.97
Characterization of methylphenidate self-administration and reinstatement in the rat. Psychopharmacology (Berl) (2008) 0.96
Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter? J Clin Psychopharmacol (2008) 0.95
Age and sex differences in the locomotor effect of repeated methylphenidate in rats classified as high or low novelty responders. Psychopharmacology (Berl) (2006) 0.95
Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol. J Med Chem (2005) 0.95
Methylphenidate and its ethanol transesterification metabolite ethylphenidate: brain disposition, monoamine transporters and motor activity. Behav Pharmacol (2007) 0.94
Ethanol consumption and place-preference conditioning in the alcohol-preferring C57BL/6 mouse: relationship with motor activity patterns. Alcohol Clin Exp Res (1999) 0.93
Assessing the stimulant effects of alcohol in humans. Pharmacol Biochem Behav (2002) 0.89
Acute methylphenidate treatments reduce sucrose intake in restricted-fed bingeing rats. Brain Res Bull (2006) 0.89
Evolution of stimulants to treat ADHD: transdermal methylphenidate. Hum Psychopharmacol (2009) 0.88
The antipsychotic aripiprazole antagonizes the ethanol- and amphetamine-induced locomotor stimulation in mice. Alcohol (2008) 0.86
Self-administration of central stimulants by rats: a comparison of the effects of d-amphetamine, methylphenidate and McNeil 4612. Pharmacol Biochem Behav (1984) 0.85
Comparative effects of ethanol on motor activity and operant behavior. Pharmacol Biochem Behav (1992) 0.82
Biphasic effect of ethanol on noradrenaline release in the frontal cortex of awake rats. Alcohol Alcohol (1992) 0.82
Enantioselective behavioral effects of threo-methylphenidate in rats. Pharmacol Biochem Behav (1991) 0.79
Ethanol stimulation after chronic exposure in C57 mice. Pharmacol Biochem Behav (1989) 0.79
Stimulatory effects of ethanol in C57BL/6 mice. Pharmacol Biochem Behav (1987) 0.78
Effects of methylphenidate on schedule dependent and schedule induced behavior. Pharmacol Biochem Behav (1979) 0.76
Homer2 is necessary for EtOH-induced neuroplasticity. J Neurosci (2005) 2.17
Homer proteins regulate sensitivity to cocaine. Neuron (2004) 1.83
Repeated cycles of chronic intermittent ethanol exposure in mice increases voluntary ethanol drinking and ethanol concentrations in the nucleus accumbens. Psychopharmacology (Berl) (2008) 1.76
Advances in the pharmacotherapy of attention-deficit-hyperactivity disorder: focus on methylphenidate formulations. Pharmacotherapy (2003) 1.57
Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis. Am J Hum Genet (2008) 1.50
Behavioral and neurochemical interactions between Group 1 mGluR antagonists and ethanol: potential insight into their anti-addictive properties. Drug Alcohol Depend (2006) 1.33
Development of an alcohol deprivation and escalation effect in C57BL/6J mice. Alcohol Clin Exp Res (2006) 1.21
CYP3A4 is a human microsomal vitamin D 25-hydroxylase. J Bone Miner Res (2003) 1.19
CYP3A4 is a vitamin D-24- and 25-hydroxylase: analysis of structure function by site-directed mutagenesis. J Clin Endocrinol Metab (2004) 1.18
A comprehensive in vitro screening of d-, l-, and dl-threo-methylphenidate: an exploratory study. J Child Adolesc Psychopharmacol (2006) 1.10
Long-term consequences of methamphetamine exposure in young adults are exacerbated in glial cell line-derived neurotrophic factor heterozygous mice. J Neurosci (2007) 1.07
Role of Ca2+-independent phospholipase A2gamma in Ca2+-induced mitochondrial permeability transition. J Pharmacol Exp Ther (2007) 1.05
Impact of sex: determination of alcohol neuroadaptation and reinforcement. Alcohol Clin Exp Res (2006) 1.01
Voluntary ethanol drinking in mice and ethanol concentrations in the nucleus accumbens. Brain Res (2006) 0.98
Highly active antiretroviral therapy and human immunodeficiency virus encephalitis. Ann Neurol (2005) 0.98
Unconditioned and conditioned factors contribute to the 'reinstatement' of cocaine place conditioning following extinction in C57BL/6 mice. Behav Brain Res (2002) 0.97
Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter? J Clin Psychopharmacol (2008) 0.95
Topiramate reduces ethanol consumption by C57BL/6 mice. Synapse (2007) 0.95
Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol. J Med Chem (2005) 0.95
Methylphenidate and its ethanol transesterification metabolite ethylphenidate: brain disposition, monoamine transporters and motor activity. Behav Pharmacol (2007) 0.94
Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults. Clin Pharmacokinet (2003) 0.92
The severe combined immunodeficient (SCID) mouse model of human immunodeficiency virus encephalitis: deficits in cognitive function. J Neurovirol (2004) 0.91
Inducible nitric oxide synthase inhibitors reduce urinary markers of systemic oxidant stress in murine proliferative lupus nephritis. J Investig Med (2005) 0.89
Highly active antiretroviral therapy of cognitive dysfunction and neuronal abnormalities in SCID mice with HIV encephalitis. Exp Neurol (2007) 0.89
Conditioned stimulus-induced reinstatement of extinguished cocaine seeking in C57BL/6 mice: a mouse model of drug relapse. Brain Res (2003) 0.88
The role of the polymorphic efflux transporter P-glycoprotein on the brain accumulation of d-methylphenidate and d-amphetamine. Drug Metab Dispos (2006) 0.87
Interactive effects of methylphenidate and alcohol on discrimination, conditioned place preference and motor coordination in C57BL/6J mice. Psychopharmacology (Berl) (2012) 0.87
Enantiospecific determination of DL-methylphenidate and DL-ethylphenidate in plasma by liquid chromatography-tandem mass spectrometry: application to human ethanol interactions. J Chromatogr B Analyt Technol Biomed Life Sci (2011) 0.86
A dual-hit animal model for age-related parkinsonism. Prog Neurobiol (2009) 0.85
An assessment of pharmacokinetics and antioxidant activity of free silymarin flavonolignans in healthy volunteers: a dose escalation study. Drug Metab Dispos (2013) 0.85
Enhanced dopamine transporter activity in middle-aged Gdnf heterozygous mice. Neurobiol Aging (2010) 0.85
Transdermal and oral dl-methylphenidate-ethanol interactions in C57BL/6J mice: transesterification to ethylphenidate and elevation of d-methylphenidate concentrations. J Pharm Sci (2011) 0.84
Effects of vigabatrin, an irreversible GABA transaminase inhibitor, on ethanol reinforcement and ethanol discriminative stimuli in mice. Behav Pharmacol (2012) 0.84
Minocycline restores striatal tyrosine hydroxylase in GDNF heterozygous mice but not in methamphetamine-treated mice. Neurobiol Dis (2008) 0.83
Oral and transdermal DL-methylphenidate-ethanol interactions in C57BL/6J mice: potentiation of locomotor activity with oral delivery. Pharmacol Biochem Behav (2011) 0.82
Evidence for a relationship between Group 1 mGluR hypofunction and increased cocaine and ethanol sensitivity in Homer2 null mutant mice. Ann N Y Acad Sci (2003) 0.82
Prenatal LPS increases inflammation in the substantia nigra of Gdnf heterozygous mice. Brain Pathol (2010) 0.81
The dopamine D1 antagonist reduces ethanol reward for C57BL/6 mice. Alcohol Clin Exp Res (2004) 0.81
Differential neurosensitivity to the discriminative stimulus properties of ethanol in C57BL/6J and C3H/He mice. Alcohol Clin Exp Res (2004) 0.81
Enantiospecific gas chromatographic-mass spectrometric analysis of urinary methylphenidate: implications for phenotyping. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 0.81
Differential effects of the dopamine neurotoxin MPTP in animals with a partial deletion of the GDNF receptor, GFR alpha1, gene. Brain Res (2008) 0.81
Tiagabine reduces ethanol reward in C57BL/6 mice under acute and chronic administration regimens. Synapse (2005) 0.80
The nigrostriatal dopamine system of aging GFRalpha-1 heterozygous mice: neurochemistry, morphology and behavior. Eur J Neurosci (2008) 0.80
The discriminative stimulus properties of methylphenidate in C57BL/6J mice. Behav Pharmacol (2011) 0.79
Isopropylphenidate: an ester homolog of methylphenidate with sustained and selective dopaminergic activity and reduced drug interaction liability. J Child Adolesc Psychopharmacol (2013) 0.78
Oral administration of a decaffeinated green tea (Camellia sinensis) extract did not alter urinary 8-epi-prostaglandin F(2 alpha), a biomarker for in-vivo lipid peroxidation. J Pharm Pharmacol (2005) 0.78
A novel HPLC fluorescence method for the quantification of methylphenidate in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 0.77
Ethanol Interactions With Dexmethylphenidate and dl-Methylphenidate Spheroidal Oral Drug Absorption Systems in Healthy Volunteers. J Clin Psychopharmacol (2017) 0.75
Given the multifaceted nature of ADHD, namely its physiologic, cognitive, psychological, and behavioral manifestations, multimodal approaches to treatment are advocated. Introduction. J Clin Psychopharmacol (2008) 0.75